Combined BET bromodomain and DNMT inhibition targets critical survival pathways in transdifferentiated prostate cancer

Press/Media

Period	12 Aug 2026

Media coverage

Title	Combined BET bromodomain and DNMT inhibition targets critical survival pathways in transdifferentiated prostate cancer
Media name/outlet	JCI Insight
Country/Territory	United States
Date	12/08/26
URL	ct.moreover.com/?a=60159775062&p=1gw&v=1&x=bOYELd7eGHwUa-gwJx8wpA
Persons	Leigh Ellis